Sutton Wealth Advisors Inc. Corcept Therapeutics Inc Transaction History

Sutton Wealth Advisors Inc.

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Nov 07, 2023	SELL	$19.2 - $24.47 $31,814 - $40,546	-1,657 Closed	0 $0
Q4 2022 Nov 07, 2023	BUY	$19.95 - $29.96 $219 - $329	11 Added 0.67%	1,657 $33.7 Million
Q3 2022 Nov 07, 2023	BUY	$24.7 - $29.12 $444 - $524	18 Added 1.11%	1,646 $42.2 Million
Q2 2022 Nov 07, 2023	SELL	$17.33 - $25.3 $190 - $278	-11 Reduced 0.67%	1,628 $38.7 Million
Q1 2022 Nov 07, 2023	BUY	$16.53 - $25.21 $2,380 - $3,630	144 Added 9.63%	1,639 $36.9 Million
Q4 2021 Nov 07, 2023	SELL	$17.1 - $23.34 $2,308 - $3,150	-135 Reduced 8.28%	1,495 $29.6 Million
Q3 2021 Nov 07, 2023	BUY	$19.68 - $22.53 $3,129 - $3,582	159 Added 10.81%	1,630 $32.1 Million
Q3 2020 Nov 07, 2023	BUY	$12.46 - $19.98 $2,990 - $4,795	240 Added 19.5%	1,471 $25.6 Million
Q1 2020 Nov 07, 2023	SELL	$10.11 - $14.04 $4,792 - $6,654	-474 Reduced 27.8%	1,231 $14.6 Million
Q3 2019 Nov 07, 2023	BUY	$10.41 - $14.66 $17,749 - $24,995	1,705 New	1,705 $24.1 Million
Q2 2019 Nov 06, 2023	SELL	$9.78 - $12.76 $13,515 - $17,634	-1,382 Closed	0 $0
Q1 2019 Nov 06, 2023	SELL	$10.03 - $15.71 $1,785 - $2,796	-178 Reduced 11.41%	1,382 $16.2 Million
Q4 2018 Nov 06, 2023	BUY	$11.29 - $17.19 $2,698 - $4,108	239 Added 18.09%	1,560 $20.8 Million
Q3 2018 Nov 06, 2023	BUY	$12.27 - $15.65 $16,208 - $20,673	1,321 New	1,321 $18.5 Million
Q2 2018 Nov 06, 2023	SELL	$15.3 - $19.69 $21,159 - $27,231	-1,383 Closed	0 $0
Q1 2018 Nov 06, 2023	BUY	$14.59 - $25.5 $20,177 - $35,266	1,383 New	1,383 $22.8 Million

311

87.9M

1.07M

973K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.16B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.